Wird geladen...
Angiotensin II blockade: A therapeutic strategy with wide applications
Evidence now exists suggesting a pathologic role for angiotensin II in patients with cardiovascular disease and those with risk factors. Clinical trials such as the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE), the Heart Outcomes Prevention Evaluation Study (HOPE), the A...
Gespeichert in:
| Veröffentlicht in: | Clin Cardiol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley Periodicals, Inc.
2006
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653952/ https://ncbi.nlm.nih.gov/pubmed/14640463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261104 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|